1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Maple Leaf Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-Drug Interaction Study in Trans Women Living With HIV Biktarvy 50/200/25 Tab, Estradiol Tablets - Hiv, Transgenderism | Phase 4 | Unknown | Maple Leaf Research | 45 | 2022-11-23 | 2024-09-26 |
| PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 Tenofovir/emtricitabine - HIV, Human Immunodeficiency Virus | Phase 4 | Completed | Unity Health Toronto | 52 | 2014-10-01 | 2016-10-17 |
Acquired Immunodeficiency Syndrome (2) · Transsexualism (1)
Emtricitabine (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Estradiol (1) · Tenofovir (1)
Canada (2)
Darrell Tan, MD FRCPC PhD (1) · Mona Loutfy, MD, MPH (1)